SEATTLE, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.

More:
Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh